TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells

被引:0
|
作者
Ji, Wenmin [1 ,3 ]
Wang, Wenyan [2 ]
Wei, Yanfang [1 ]
机构
[1] Shanxi Med Univ, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Inst Food & Drug Control, Taiyuan 030001, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 1, 85 Jiefang South Rd, Taiyuan 030000, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 11期
关键词
PD-1/PD-L1; TP53TG1; immune escape; STAT pathway; colon cancer; REGULATORY T-CELLS; LONG NONCODING RNA; CD8(+) T; IMMUNOTHERAPY; COMBINATION; THERAPY; TARGET; RESISTANCE; PROGNOSIS; CD4(+);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research is dedicated to investigating the mechanism of programmed cell death ligand 1 (PD-L1) and tumor protein 53 target gene 1 (TP53TG1) in immune regulation of colon cancer (CC). Expressions of TP53TG1, PDL1 and signal transducers and activators of transcription (STATs) in CC and their correlation were detected through bioinformatics analysis. Effects of PD-L1 and TP53TG1 on the CC were assessed by in vivo and in vitro experiments. Herein, PD-L1 level was negatively correlated with TP53TG1 expression, but was positively correlated with the levels of STATs. Both overexpressed TP53TG1 and PD-L1 antibody reversed the effects of CT26 cells on inhibiting cell proliferation, cytokine secretion and PD-L1 level, and enhancing the cytotoxicity of NK cells and CD8+ T cells. TP53TG1 reduced PD-L1 level by inactivating STATs pathway. Downregulation of PD-L1 increased cytokine secretion and T lymphocyte killing ability, promoted tumor cell apoptosis, and inhibited the tumor growth. Altogether, TP53TG1/STAT axis regulates the immunomodulatory mechanism of CC by reducing PD-L1 expression.
引用
收藏
页码:5218 / +
页数:19
相关论文
共 50 条
  • [1] Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
    Noguchi, Takuro
    Ward, Jeffrey P.
    Gubin, Matthew M.
    Arthur, Cora D.
    Lee, Sang Hun
    Hundal, Jasreet
    Selby, Mark J.
    Graziano, Robert F.
    Mardis, Elaine R.
    Korman, Alan J.
    Schreiber, Robert D.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (02) : 106 - 117
  • [2] The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma
    Gabrych, Anna
    Peksa, Rafal
    Kunc, Michal
    Krawczyk, Malgorzata
    Izycka-Swieszewska, Ewa
    Biernat, Wojciech
    Bien, Ewa
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [3] PD-1/PD-L1 axis importance and tumor microenvironment immune cells
    Lotfinejad, Parisa
    Kazemi, Tohid
    Mokhtarzadeh, Ahad
    Shanehbandi, Dariush
    Niaragh, Farhad Jadidi
    Safaei, Sahar
    Asadi, Milad
    Baradaran, Behzad
    LIFE SCIENCES, 2020, 259
  • [4] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    Iwai, Y
    Ishida, M
    Tanaka, Y
    Okazaki, T
    Honjo, T
    Minato, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12293 - 12297
  • [5] SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1–PD-L1 axis
    Kun Gao
    Qing Shi
    Ye Gu
    Wanqi Yang
    Yuanlong He
    Zeheng Lv
    Yan Ding
    Wenxin Cao
    Chenji Wang
    Xiaoping Wan
    Cell Death & Differentiation, 2023, 30 : 475 - 487
  • [6] Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
    Michaël Cerezo
    Ramdane Guemiri
    Sabine Druillennec
    Isabelle Girault
    Hélène Malka-Mahieu
    Shensi Shen
    Delphine Allard
    Sylvain Martineau
    Caroline Welsch
    Sandrine Agoussi
    Charlène Estrada
    Julien Adam
    Cristina Libenciuc
    Emilie Routier
    Séverine Roy
    Laurent Désaubry
    Alexander M. Eggermont
    Nahum Sonenberg
    Jean Yves Scoazec
    Alain Eychène
    Stéphan Vagner
    Caroline Robert
    Nature Medicine, 2018, 24 : 1877 - 1886
  • [7] Mechanisms regulating PD-L1 expression on tumor and immune cells
    Chen, Shuming
    Crabill, George A.
    Pritchard, Theresa S.
    McMiller, Tracee L.
    Wei, Ping
    Pardoll, Drew M.
    Pan, Fan
    Topalian, Suzanne L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [8] Acidosis promotes immune escape by interferon-γ-induced transcriptional induction of PD-L1 via the elF4F-STAT1-PD-L1 axis on cancer cells
    Knopf, P.
    Hoffmann, S.
    Hermann, N.
    Maurer, A.
    Bucher, V.
    Poxleitner, M.
    Tako, B.
    Sonanini, D.
    Sinharay, S.
    Fehrenbacher, B.
    Gonzalez-Menendez, I.
    Kramer, D.
    Schaller, M.
    Quintanilla-Martinez, L.
    Schulze-Osthoff, K.
    Pagel, M.
    Martins, A. Ferreira
    Fransen, M.
    Pichler, B. J.
    Ghoreschi, K.
    Kneilling, M.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E99 - E99
  • [9] Metformin suppresses tumor immune evasion through downregulation of PD-L1 expression in cancer cells and PD-1 expression in NK cells and T cells
    Park, Su Hwan
    Lee, Jong-Ho
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Tumor-derived microvesicles promote tumor immune escape through PD-1/PD-L1 interaction
    Kim, Dong Ha
    Choi, Yun Jung
    Kim, Seon Ye
    Lee, Jung-Eun
    Sung, Ki Jung
    Lee, Jae Cheol
    Rho, Jin Kyung
    CANCER RESEARCH, 2018, 78 (13)